Literature DB >> 15964724

Maintaining the cold chain shipping environment for Phase I clinical trial distribution.

M A Elliott1, G W Halbert.   

Abstract

The study aimed to demonstrate satisfactory inter-UK transit of cold storage clinical trial material. The product environment had to be maintained between 0 and 8 degrees C throughout transit until delivery. Straightforward, low cost and simplified shipping arrangements were sought that would be appropriate for small-scale Phase I clinical trial activities. A laboratory test defined an optimal three frozen gel pack configuration to maintain refrigerated environmental conditions for dummy product packs in a single type and size of insulated shipper. The internal environment was temperature monitored at 30-min intervals in all tests. Twelve Glasgow to London transits were then studied over 2 years to include all seasonal temperature variations. A configuration using three frozen gel packs and 4 h pre-chill of the transit container maintained the internal environment at 0-8 degrees C for up to 48 h during autumn, winter and spring. A modified four frozen gel pack configuration was suitable for summer transit. Thus cold shipment verification was successfully carried out for a small-scale distribution operation. It was proven that refrigerated shipping conditions could be maintained using a straightforward and cost effective 'passive' type system consisting of frozen gel packs and insulated transit containers.

Mesh:

Year:  2005        PMID: 15964724     DOI: 10.1016/j.ijpharm.2005.04.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Room temperature shipment does not affect the biological activity of pluripotent stem cell-derived retinal organoids.

Authors:  Maria Georgiou; Valeria Chichagova; Gerrit Hilgen; Birthe Dorgau; Evelyne Sernagor; Lyle Armstrong; Majlinda Lako
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

2.  The effect of temperature exposure during shipment on a commercially available demineralized bone matrix putty.

Authors:  Mark Schallenberger; Helena Lovick; Jalane Locke; Todd Meyer; Gregory Juda
Journal:  Cell Tissue Bank       Date:  2016-08-25       Impact factor: 1.522

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.